Top Articles
#1 in Business Subscribe Email Print

You are here: Home > Legal > Copyright > Licensing Your Copyrighted Works

Tags

  • product
  • exchange
  • articles
  • companies involved
  • developing combination
  • companies involved

  • Links

  • What I Now Look For in My Cellular Phone Service
  • Fix Registry Problems- They Attack The Brain of Your System
  • The Most Romantic Cottage in the World
  • Top Articles - Licensing Your Copyrighted Works

    If you’ve taken the necessary steps to register your copyrighted works, you inevitably will have an opportunity to royalties off of them.
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    To take advantage of the opportunity, you will need to be familiar with copyright license agreements.

    Copyright License Agreement

    A co
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    pyright license agreement sets for the terms under which a third party can use your content. In legal language, you will the “licensor” w
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    th the other party being the “licensee.” The purpose of the agreement is to set forth the terms under which you, the licensor, will gran
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    t the third party, licensee, the right to use, publish or reuse your copyrighted work in exchange for a royalty. Let’s take a closer look
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    at key components of the licensing agreement.

    Specific Rights Granted

    This may sound obvious, but the agreement needs to detail exactly
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    what copyrighted material can be used. If you have copyrighted articles, are you granting a right to use all of the articles or only cer
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ain ones? It is highly recommended that the agreement contain a detailed description of the exact materials being covered.

    Once you agre
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    e upon the exact materials, you need to determine any restrictions on how the material can be used. Can the material be used on the Inter
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    et or will it be restricted to a certain niche’ such as manuals or collections of materials?

    An extremely important issue is whether the
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    agreement grants exclusive or non-exclusive rights. In English, this simply defines whether the licensor can grant similar rights to oth
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    er parties. The grant of exclusive licenses should require a much larger royalty rate since you are essentially betting the third party w
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ll be successful.

    Licensing Royalties

    In exchange for your copyrighted work, the third party is going to make royalty payments to you.
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    The particular amount of the royalty is dependent upon the nature of your work. Issues to consider include:

    1) Will you be paid a flat a
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ount or percentage of sales?

    2) If a percentage, will it be figured from gross revenues or something less?

    3) How often will you be pai
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    d?

    4) What rights will you have to audit the books of the third party to determine you are getting the full royalty?

    In some situations
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    you may decide to forgo a royalty payment. This usually occurs when the third party will use the materials in manner that produces massi
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ve publicity for you. For example, many professionals seek to right columns for publications as a marketing tool. Often, they will not ch
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    rge the publication for the material because the resulting publicity carries enough of a benefit.

    In Closing

    If you are considering lic
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ensing copyrighted content, keep the above in mind. Since such agreements are difficult to break, hiring an attorney is worth the expense


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.toparticles.org.ua/article/129444/toparticles-Licensing-Your-Copyrighted-Works.html">Licensing Your Copyrighted Works</a>

    BB link (for phorums):
    [url=http://www.toparticles.org.ua/article/129444/toparticles-Licensing-Your-Copyrighted-Works.html]Licensing Your Copyrighted Works[/url]

    Related Articles:

    Catching Someone Trying to Get Business Intelligence

    Tools To Make Web Marketing Easier

    Common Sense Link Exchange

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com